Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand

Dr. Saiqa Mullick is Director of Implementation Science, responsible for leading the development and implementation of a large portfolio of programmatic research and technical assistance. Her qualifications include a medical degree, two Masters level degrees in Public Health Methodology and in Public Health in Developing Countries. She is completing a PhD in Epidemiology and also a Member of the Institute of Directors of Southern Africa (IoDSA).
Saiqa has 18 years’ experience in public health, implementation science, program monitoring and evaluation, reproductive health and HIV, technical assistance and capacity building in developing country settings including Kenya, Lesotho, Swaziland, Zimbabwe, Tanzania and South Africa. She has extensive experience in the design, conduct of implementation science studies and has worked closely with governments, NGOs and stakeholders to promote utilisation of research through support to policy and guideline development at national and global level. She currently serves as Principal Investigator on a national initiative providing technical support to programming for adolescent girls and young women and is also Deputy Director of OPTIONS, a multi-country program supporting creative research and innovation critical to advancing potential ARV-based HIV prevention products in selected countries. Prior to joining Wits RHI she was Country Director for the Population Council’s South Africa office and Regional Associate Director for Africa with the Population Council under the $120 million USAID program FRONTIERS.
She is recognised as an expert in her field as evidenced by her involvement as an advisor at provincial, national and global levels. She has served as an advisor to WHO on several occasions, including as a technical expert on the Global STI Guideline Development Group, the Global Guideline Development Group for post-exposure prophylaxis of HIV (PEP), Global STI Guideline Development Group, the Global Strategy for Elimination of Congenital Syphilis and Global Strategy for Control of STIs. She was a core team member for development of WHO guidelines “Sexually Transmitted and other Reproductive Tract Infections–A guide to Essential Practice, and was appointed to serve for four-year term on WHO Expert Technical Advisory Panel on STIs including HIV. She currently serves as Board Member for the AIDS Consortium, the linking organisation for the International AIDS Alliance with over 200 affiliate organisations in South Africa.

Experience

  • –present
    Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand